Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024
Compare Balance Sheet Results of Aptus Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
3.02
1.98
65.56%
Share Warrants & Outstandings
Total Reserve
1.97
194.15
-192.18
-98.99%
Shareholder's Funds
6.97
197.18
-190.21
-96.47%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.62
17.31
-14.69
-84.86%
Secured Loans
1.51
17.31
-15.80
-91.28%
Unsecured Loans
1.11
0.00
1.11
0.00%
Deferred Tax Assets / Liabilities
-0.07
13.59
-13.66
-100.52%
Other Long Term Liabilities
0.25
1.74
-1.49
-85.63%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
4.20
-4.20
-100.00%
Total Non-Current Liabilities
2.80
36.84
-34.04
-92.40%
Current Liabilities
Trade Payables
1.31
45.98
-44.67
-97.15%
Other Current Liabilities
3.04
14.85
-11.81
-79.53%
Short Term Borrowings
7.74
61.86
-54.12
-87.49%
Short Term Provisions
0.00
1.59
-1.59
-100.00%
Total Current Liabilities
12.08
124.30
-112.22
-90.28%
Total Liabilities
21.85
358.31
-336.46
-93.90%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.86
210.61
-208.75
-99.12%
Less: Accumulated Depreciation
0.87
62.15
-61.28
-98.60%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.99
148.46
-147.47
-99.33%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.40
-0.40
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
23.23
-23.23
-100.00%
Long Term Loans & Advances
0.00
6.66
-6.66
-100.00%
Other Non Current Assets
1.12
0.00
1.12
0.00%
Total Non-Current Assets
2.11
180.52
-178.41
-98.83%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
7.06
60.58
-53.52
-88.35%
Sundry Debtors
5.64
64.53
-58.89
-91.26%
Cash and Bank
5.21
1.41
3.80
269.50%
Other Current Assets
0.00
7.20
-7.20
-100.00%
Short Term Loans and Advances
1.82
44.07
-42.25
-95.87%
Total Current Assets
19.74
177.79
-158.05
-88.90%
Net Current Assets (Including Current Investments)
7.65
53.49
-45.84
-85.70%
Total Current Assets Excluding Current Investments
19.74
177.79
-158.05
-88.90%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
21.85
358.31
-336.46
-93.90%
Contingent Liabilities
0.00
23.58
-23.58
-100.00%
Total Debt
10.36
79.17
-68.81
-86.91%
Book Value per share (adjusted)
13.93
652.19
-638.26
-97.86%
Annual - Borrowings
Borrowings 10.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 19.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024






